Actavis Fights For Earlier 2nd Circ. Date In Antitrust Suit
Actavis PLC urged the Second Circuit Thursday to hear its appeal of an injunction forcing the company to continue making an older version of dementia treatment Namenda by mid-March, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article